Background Image
Table of Contents Table of Contents
Previous Page  12 / 44 Next Page
Information
Show Menu
Previous Page 12 / 44 Next Page
Page Background

10

VOLUME 14 NUMBER 1 • JULY 2017

REVIEW

SA JOURNAL OF DIABETES & VASCULAR DISEASE

quality of life. Identifying a treatment modality to help resolve this

complication remains a difficult task in clinical practice. However a

number of clinical trials suggest LLLT as an alternative and promising

treatment modality that, when combined with other conventional

treatments, has shown potential in improving the healing rate of

chronic diabetic ulcerations. It is therefore essential to recognise

that with the use of LLLT in podiatry and other wound clinics, the

treatment or management of chronic diabetic lower-limb ulcerations

can be reduced to an average of 19 sessions to achieve a complete

recovery,

43

compared to 40 sessions using conventional treatments

alone.

5,46

This could lead to reduced hospital admissions for people

with diabetic ulcers and lighten the substantial public health and

socio-economic burden to our country. Further investigations are

necessary to obtain conclusive evidence of low-level laser in treating

diabetic foot ulcers in South Africa.

Acknowledgements

This work is based on research supported by the University of

Johannesburg and the South African Research Chairs Initiative of

the Department of Science and Technology and National Research

Foundation of South Africa (Grant No 98337). The authors thank

the National Laser Centre for the supply and servicing of lasers.

References

1.

Mbanya JCN, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan

Africa.

Lancet

2010;

375

: 2254–2266.

2.

International Diabetes Federation. Diabetes Atlas, 7th edn. Brussels: International

Diabetes Federation, 2015

3.

Rheeder P. Type 2 diabetes: the emerging epidemic.

S Afr Family Prac

2006;

48

(10): 20.

4.

Edmonds ME. Metabolic disorders. In: Lorimer D, Frowen P, O’Donnell M, Burrow

G.

Neal’s Disorders of the Foot

, 8th edn. Europe: Churchill Livingstone, 2010;

246–249.

5.

Minatel DG, Frade MAC, Franca SC, Enwemeka CS. Phototherapy promotes

healing of chronic diabetic leg ulcers that failed to respond to other therapies.

Laser Surg Med

2009;

41

: 433–441.

6.

Clarke A. Avoiding foot complications in diabetes.

Contin Med Ed

2010;

28

(4):

181–185.

7.

Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in

diabetes.

J Clin Invest

2007;

117

: 1219–1222.

8.

Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and

healing.

J Vasc Surg

2010;

52

: 37S–43S.

9.

Bergin SM, Wraight PR, Burr JM. Australian diabetes foot network: management

of diabetes-related foot ulceration – a clinical update.

Med J Australia

2012;

197

:

226–229.

10. Guo S, Di Pietro LA. Factors affecting wound healing.

J Dent Res

2010;

89

(3):

219–229.

11. Jain AKC. A new classification of diabetic foot complications: a simple and

effective teaching tool.

J Diabetic Foot Complicat

2012;

4

(1): 1–5

12. Beckmann KH, Meyer-Hamme G, Schröder S. Low level laser therapy for the

treatment of diabetic foot ulcers: a critical survey.

Evidence-Based Comp Alt Med

2014

; 2014: 1–9.

13. Chadwick P, Edmonds M, McCardle J, Armstrong D. International best practice

guidelines: wound management in diabetic foot ulcers.

Wound Int

2013;

4

:

1–27.

14. Clarke EAM, Tsubane M. The role of a podiatrist in managing the diabetic foot

ulcer.

Wound Heal Sth Afr

2008;

1

(1): 40–42.

15. Kim PJ, Attinger CE, Evans KK. Role of a podiatrist in diabetic limb salvage.

J Vasc

Surg

2012;

56

: 1168–1172.

16. Houreld NN. Shedding light on a new treatment for diabetic wound healing: a

review of phototherapy.

Sci J

2014; 2014: 1–13.

17. Petrova N, Edmonds M. Emerging drugs for diabetic foot ulcer.

Expert Opin

Emerg Drugs

2006;

11

(4): 709–724.

18. Falanga V. Wound healing and its impairment in the diabetic foot.

Lancet

2005;

366

(9498): 1736–1743.

19. Clayton W, Elasy TA. A review of pathophysiology, classification and treatment of

foot ulcers in diabetic patients.

Clin Diabetes

2009;

27

(2): 52–58.

20. Bus SA, Valk GD, van Deursen RW,

et al.

The effectiveness of footwear and

offloading interventions to prevent and heal foot ulcers and reduce plantar

pressure in diabetes: a systematic review.

Diabetes Metab Res Rev

2008;

24

:

S162–S180.

21. Mueller MJ, Lott DJ, Hastings MK, Commean PK, Smith KE, Pilgram TK. Efficacy

and mechanism of orthotic devices to unload metatarsal heads in people with

diabetes and a history of plantar ulcers.

Phys Ther

2006;

86

(6): 833–842.

22. Tong JWK, Ng EYK. Preliminary investigation on the reduction of plantar loading

pressure with different insole materials (SRP – Slow Recovery Poron

®

, P – Poron

®

,

PPF – Poron

®

+ Plastazote, firm and PPS – Poron

®

+ Plastazote, soft).

Foot

2010;

20

: 1–6.

23. Sambrook E, Delpierre T, Bowen G. Advancing the gold standard in offloading the

diabetic foot: product evaluation.

Wounds UK EWMA Special

2015: 48–56.

24. Raspovic A, Landorf KB. A survey of offloading practices for diabetes-related

plantar neuropathic foot ulcers.

J Foot Ankle Res

2014;

7

: 35.

25. Fife CE, Carter MJ, Walker D. Why is it so hard to do the right thing in wound

care?

Wound Repair Regen

2010;

18

: 154–158.

26. Fife CE, Carter MJ, Walker D,

et al.

Diabetic foot ulcer offloading: the gap

between evidence and practice. Data from the US Wound Registry.

Adv Skin

Wound Care

2014;

27

: 310–316.

27. Armstrong DG, Wu S, Lavery LA, Boulton AJM. Evaluation of removable and

irremovable cast walkers in the healing of diabetic foot wounds: a randomized

controlled trial.

Diabetes Care

2005;

28

(3): 551–554.

28. Faglia E, Curci V,

et al.

Effectiveness of removable walker cast versus non-

removable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer:

a randomized controlled trial.

Diabetes Care

2010;

33

(7): 1419–1423.

29. Chadwick P, McCardle J, Cundell J, Towson M. Foot in Diabetes UK. The principle

of debridement: the diabetic foot. Developing Scope of Practice for Podiatrists in

the UK. 2014; 2014: 2–20.

30. Ahmad I, Akhtar S, Masoodi Z. Role of early radical debridement and skin cover

in diabetic foot ulceration.

J Wound Care

2012;

21

(9): 442–444, 446–447.

31. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp

debridement using curette on recalcitrant non-healing venous leg ulcers: A

concurrently controlled, prospective cohort study.

Wound Repair Regen

2005;

13

: 131–137.

32. Wolcott RD, Kennedy JP, Dowd SE. Regular debridement is the main tool for

maintaining a healthy wound bed in most chronic.

J Wound Care

2009;

18

(2):

55–56.

33. Cardinal M, Eisenbud DE, Armstrong DG,

et al.

Serial surgical debridement: a

retrospective study on clinical outcomes in chronic lower extremity wounds.

Wound Repair Regen

2009;

17

(3): 306–311.

34. Wilcox JR, Carter MJ, Covington S. Frequency of debridement and time to heal: a

retrospective cohort study of 312744 wounds.

J Am Med Assoc Dermatol

2013;

149

(9): 1050–1058.

35. Nteleki B, Houreld NN. The use of phototherapy in the treatment of diabetic

ulcers.

J Endocrin Metab Diabetes S Afr

2012;

17

(3): 128–132.

36. Dinh TL, Veves A. Treatment of diabetic ulcers.

Dermatol Ther

2006;

19

: 348–

355

37. Dyson M. Low level laser therapy, 2014. [article] Available from: http://www.

softlasers.com/low-level-laser-therapy-article.php.

38. Houreld NN, Abrahamse H. Low intensity laser irradiation stimulates wound

healing in diabetic wounded fibroblast cells (WS1).

Diabetes Technol Ther

2010;

12

(12): 971–978.

39. Hamblin MR, Demidova TN. Mechanism of low level laser light therapy.

Proc SPIE

2006;

6140

(614001): 1605–7422.

40. Mokmeli S, Daemi M, Shirazi ZA, Shirazi FA, Hajizadeh M. Evaluating the efficiency

of low level laser therapy (LLLT) in combination with intravenous laser therapy

(IVL) on diabetic foot ulcer, added to conventional therapy.

Lasers Med Sci

2010;

1

: 8–13.

41. Enwemeka CS, Williams D, Hollosi S, Yens D. Blue light photo destroys methicillin-

resistant Staphylococcus aureus (MRSA) in vitro.

Photomed Laser Surg

2009;

27

(2): 221–226.

42. Kajagar BM, Godhi AS, Pandit A, Khatri S. Efficacy of low level laser therapy

on wound healing in patients with chronic diabetic foot ulcers – a randomised

control trial.

Indian J Surg

2012;

74

(5): 359–363.

43. Kazemi-Khoo N. Successful treatment of diabetic foot ulcers with low-level laser

therapy.

Foot

2006;

16

: 184–187.

44. Lipovsky A, Nitzan Y, Lubart R. A possible mechanism for visible light-induced

wound healing.

Lasers Surg Med

2008;

40

(7): 509–514.

45. Ankri R, Lubart R, Taitelbaum H. Estimation of the optimal wavelengths for laser

induced wound healing.

Lasers Surg Med

2010;

42

(8):760–764.

46. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot

ulcers.

Lancet

2005;

366

: 1725–1735.